Blockonomi

Key Takeaways
TD Cowen increased AMD’s price target from $600 to $675 while maintaining its Buy recommendation
Shares began Monday’s session at $557.89 with the company valued at $909.70 billion
First-quarter earnings per share reached $1.37, surpassing the $1.29 forecast; revenue of $10.25 billion exceeded the $9.90 billion projection
Year-over-year quarterly revenue jumped 37.8%; Wall Street forecasts full-year EPS at $6.18
Several investment firms, including Cantor Fitzgerald ($700), Wells Fargo ($615), and Stifel ($635), have recently elevated their price objectives
TD Cowen upgraded its price objective for AMD from $600 to $675 on Monday while reaffirming its Buy recommendation. This adjustment was part of the firm’s comprehensive second-quarter earnings analysis covering compute and networking semiconductor companies.
The investment bank noted that industry fundamentals “remain firm” and highlighted significant AI product rollouts scheduled for the latter half of 2026 as critical catalysts for continued growth. TD Cowen additionally emphasized robust CPU demand, strengthened by agentic AI applications.
AMD started Monday’s trading at $557.89. The semiconductor giant holds a market capitalization of $909.70 billion, with shares trading within a 12-month range spanning $141.60 to $584.73.
The stock’s 50-day moving average stands at $491.60, compared to its 200-day moving average of $319.65 — illustrating the substantial rally AMD has experienced in recent trading sessions.
TD Cowen isn’t the only firm adopting a more optimistic stance. Cantor Fitzgerald elevated its price objective to $700 from $500, assigning AMD an Overweight designation. Wells Fargo adjusted its target upward to $615 from $505, also maintaining an Overweight rating.
Stifel raised its forecast to $635 from $450, highlighting AMD’s expanding presence in AI server infrastructure and EPYC CPU platforms. Goldman Sachs has similarly adopted a more favorable outlook, emphasizing accelerating agentic AI CPU demand.
Bank of America increased its target to $560 from $500 with a Buy rating in June. JPMorgan took a more conservative approach, shifting to a Neutral stance with a $385 target — representing one of the more cautious perspectives among major Wall Street firms.
MarketBeat’s consensus rating stands at Moderate Buy, with an average price target of $458.92. Among 44 analysts surveyed, 28 recommend Buy, 13 suggest Hold, and one advises Sell.
First Quarter Results Exceed Expectations
AMD’s most recent quarterly earnings, disclosed on May 5th, surpassed Wall Street forecasts. The chipmaker delivered earnings per share of $1.37 compared to the anticipated $1.29. Total revenue reached $10.25 billion, topping the consensus estimate of $9.90 billion.
Revenue expanded 37.8% versus the corresponding quarter in the prior year, when AMD generated $0.96 in earnings per share. Wall Street analysts currently project full-year EPS of $6.18.
The company’s next earnings announcement is anticipated around August 4th, with several market observers expecting another potential beat-and-raise performance.
Institutional Investment Trends
Regarding institutional positioning, Teachers Retirement System of Kentucky expanded its AMD holdings by 1.8% during the first quarter, elevating its position to 353,090 shares valued at approximately $71.8 million.
Norges Bank initiated a substantial new AMD position worth nearly $4.93 billion in the fourth quarter. Jennison Associates expanded its stake by 181.6% during the same timeframe. Franklin Resources increased its holdings by 340.1%.
Institutional investors and hedge funds collectively control 71.34% of AMD’s total shares outstanding.
On the insider transaction front, EVP Paul Darren Grasby divested shares valued at more than $10.8 million in May, while EVP Mark Papermaster sold approximately $3.2 million worth of stock in June through a pre-established 10b5-1 trading arrangement.
AMD also unveiled a new AI campus collaboration, creating an additional channel linked to large-scale artificial intelligence infrastructure investment.
The post Advanced Micro Devices (AMD) Stock Surges as Wall Street Analysts Boost Price Targets appeared first on Blockonomi.

Key Highlights
Shares of ALAB tumbled up to 14% Monday, declining to approximately $353 from Friday’s close of $412.97
Major stock liquidations by Board Chairman Manuel Alba and Director Stefan Dyckerhoff triggered selling pressure
Semiconductor sector faced headwinds following U.S.-Iran military action and Asian chip stock weakness
Despite the selloff, shares maintain a 113% gain year-to-date
Analyst consensus shows “Moderate Buy” with an average target price of $265.75
Astera Labs (ALAB) experienced a significant decline Monday, plummeting as much as 14% during intraday trading to approximately $353, marking a steep drop from its Friday closing price of $412.97. Trading volume remained notably light at roughly 547,000 shares compared to the typical daily average exceeding 5.6 million.
The sharp downturn stemmed from a convergence of negative factors. Executive stock sales, deteriorating macroeconomic sentiment, and index-related adjustments all pressured shares simultaneously.
Regulatory disclosures revealed Board Chairman Manuel Alba disposed of 173,366 shares through multiple transactions, with execution prices between $442 and $458. Director Stefan Dyckerhoff offloaded another 12,500 shares at $450 per share. These transactions occurred through previously established Rule 10b5-1 trading arrangements.
Throughout the past three months, company insiders collectively unloaded approximately $507 million in stock—a figure that has raised eyebrows among market participants.
Semiconductor Sector Faces Widespread Pressure
The chip industry encountered significant headwinds following weakness in South Korean giants Samsung and SK Hynix, which dragged down the KOSPI index and created ripple effects across U.S. semiconductor stocks.
Investor sentiment soured further after the United States conducted military operations against Iran late Sunday. Oil prices jumped on the developments, while U.S. Central Command announced Iran had lost control of the Strait of Hormuz, sparking concerns about potential supply chain disruptions.
The broader market declined with the Nasdaq dropping 1.74% and the S&P 500 falling 0.68%, as high-growth technology stocks bore the brunt of the selling.
Index Changes and Sector Rotation
ALAB joined the Nasdaq-100 index on June 22. Anticipation of this inclusion drove passive fund accumulation in preceding weeks, propelling the stock higher. This supportive dynamic has now shifted, with rebalancing activities adding to downward pressure.
Market participants are simultaneously shifting capital away from high-momentum technology names toward more defensive positions in healthcare and utility sectors.
From a technical perspective, shares now trade 12.8% beneath their 20-day moving average. The Relative Strength Index registers at 46, having retreated from June’s overbought territory but not yet reaching oversold conditions. Key support appears around the $303 level, while resistance emerges near $372.
Core Business Performance Stays Robust
The selloff notwithstanding, ALAB’s operational results continue to impress. The company’s latest quarterly report showed earnings per share of $0.61, surpassing analyst projections by $0.07. Revenue reached $308 million, representing 93.5% year-over-year growth and exceeding the $292 million Street estimate.
Management provided Q2 2026 EPS guidance ranging from $0.68 to $0.70. The analyst community forecasts full-year earnings per share of $1.88 on average.
Valuation remains stretched with a PE ratio of 251 and market capitalization of $63.77 billion. Among the 23 analysts covering the stock, 12 recommend Buy while 11 suggest Hold, establishing a Moderate Buy consensus. The mean price target of $265.75 sits substantially below current trading levels even after Monday’s correction.
ALAB traded down 13.45% at $399 as of publication time.
The post Astera Labs (ALAB) Stock Plunges 14% Amid Heavy Insider Selling appeared first on Blockonomi.

Key Highlights
President Trump declared the US will restore its Strait of Hormuz blockade while imposing a 20% fee on all transported cargo
Brent crude surged approximately 4.7% toward $80 per barrel; WTI climbed 4.6% approaching $75
Maritime traffic through the Hormuz strait plummeted 52% on a weekly basis, with ships disabling tracking systems
Tehran dismissed Trump’s statements and cautioned neighboring nations that US cooperation would constitute an act of aggression
Current oil values stay significantly beneath the wartime peaks exceeding $100 per barrel recorded in March
Crude oil markets experienced substantial gains Monday following President Trump’s declaration that the United States would restore its Strait of Hormuz blockade while implementing a 20% levy on all cargo transiting the critical waterway.
Brent crude advanced approximately 4.7% to reach levels near $80 per barrel. WTI crude posted comparable gains of 4.6%, trading close to $75. Despite these increases, both oil benchmarks continue trading substantially below their conflict-driven peaks surpassing $100 per barrel, established in March during the initial stages of hostilities.
Brent Crude Oil Last Day Financ (BZ=F)
Trump proclaimed the United States would assume the role of “Guardian of the Strait of Hormuz” while asserting compensation is warranted for maintaining route security. “We can’t be expected to do that for nothing,” the president stated during a Fox News appearance.
“As a matter of fairness, the United States should be reimbursed at a rate of 20% on all cargo shipped for the expenses associated with ensuring safety and security in this highly volatile corridor,” Trump wrote in a social media statement.
BREAKING: President Trump says the US is reinstating its blockade of the Strait of Hormuz for Iranian ships and customers.
Trump says the US will now be known as "The Guardian of the Strait of Hormuz" and will be "reimbursed" at a rate of 20% on all cargo shipped.
It appears… pic.twitter.com/MtjidgWMMM
— The Kobeissi Letter (@KobeissiLetter) July 13, 2026
Military Operations Intensify
US armed forces executed attacks against approximately 140 targets during the weekend, according to confirmation from US Central Command. This expanded Washington’s three-day offensive to over 300 total targets, following an assault on the Cyprus-registered container vessel M/V GFS Galaxy.
Tehran responded with strikes targeting what Iranian officials characterized as American and coalition military installations throughout the Gulf region. The United Arab Emirates reported successfully intercepting Iranian projectiles and unmanned aircraft. Emergency alerts activated in Bahrain, while detonations were documented in Doha.
Iran’s Revolutionary Guard Corps announced the interception of two ships within the strait, alleging they utilized prohibited navigation routes. Iranian authorities subsequently declared the waterway closed “until further notice.”
Trump pronounced the peace accord defunct. Iranian officials stated the situation had “undoubtedly entered a crisis phase.”
Maritime Activity Collapses, Markets Monitor Developments
Vessel transits through the Strait of Hormuz declined 52% week-over-week throughout the weekend, based on data from intelligence provider Kpler. Certain ships are now conducting “dark” passages, deactivating positioning transponders to evade surveillance.
The strategic waterway handles approximately one-fifth of global crude oil supply. With worldwide petroleum stockpiles depleted following five months of armed conflict, and Chinese refining demand showing renewed growth, supply constraints are intensifying.
Behind-the-Scenes Diplomatic Efforts Persist
Iran’s Foreign Minister conducted discussions with his Omani equivalent in Muscat regarding secure transit arrangements through the strait. Omani officials indicated negotiations would advance through both political and technical channels.
Iran’s newly installed Supreme Leader Ayatollah Mojtaba Khamenei pledged to seek retribution for his father’s death—the former supreme leader who perished in February when the conflict commenced.
Tehran stated it would not honor ceasefire provisions if Washington continues military operations. The United States has stipulated Iran must ensure safe commercial shipping passage before comprehensive negotiations can proceed.
The post Trump’s Hormuz Blockade and 20% Cargo Tax Drive Oil Prices Higher appeared first on Blockonomi.

Key Highlights
Intel plans to deploy €5 billion ($5.7 billion) to upgrade its Leixlip, Ireland facility for enhanced AI chip manufacturing.
The expansion targets increased production of Xeon server processors while strengthening R&D capabilities at Intel’s European operations center.
Approximately 30% of Intel’s projected $17 billion 2026 capital expenditure will be allocated to this project, with completion targeted by late 2027.
Earlier this year, Intel spent $14.2 billion reacquiring 50% ownership of the Irish facility from Apollo Global Management.
The project is projected to generate hundreds of new positions, supplementing Intel’s current 4,900 employees in Ireland.
Intel has committed €5 billion ($5.7 billion) toward expanding its Leixlip facility near Dublin, marking a significant investment in its primary European production site as the company works to capture growing AI and high-performance computing market opportunities. When the announcement was made, INTC stock had declined 6.06%.
The capital injection will finance upgrades to current fabrication infrastructure and acquisition of cutting-edge manufacturing tools. According to Intel, the Leixlip location currently stands as Europe’s most sophisticated semiconductor production complex.
The project aims to increase production volumes for Intel Xeon 6 processors alongside future-generation Xeon products manufactured using Intel’s Intel 3 process technology. Naga Chandrasekaran, Executive Vice President of Intel Foundry, stated, “The demand for servers, the demand for AI is driving a significant increase in the need for Intel 3 wafers.”
INTEL $INTC IS INVESTING $5.7B, TO EXPAND MANUFACTURING AT ITS LEIXLIP CAMPUS IN IRELAND.
The investment will upgrade existing fabs, install new leading-edge equipment, and expand capacity for Xeon 6 and next-gen Xeon processors built on the Intel 3 node.
Intel says the project… pic.twitter.com/ti2RhHQlKH
— Wall St Engine (@wallstengine) July 13, 2026
The bulk of investment dollars will be spent before 2027 concludes. This €5 billion commitment accounts for approximately 30% of Intel’s complete projected capital spending of $17 billion planned for 2026.
Since establishing its European headquarters in Ireland in 1989, Intel has channeled over €30 billion into the country. More than half that amount was invested during the 2019-2023 period on a fabrication plant that effectively doubled Ireland’s semiconductor manufacturing capacity.
Foundry Business Expansion
The Leixlip upgrade connects directly to Intel’s wider foundry strategy. Chandrasekaran explained that the investment will partially serve to expand manufacturing capacity for Intel Foundry clients — the business unit producing chips for external customers that represents a cornerstone of Intel’s competitive repositioning against companies like TSMC.
Intel remains in the foundational phases of establishing its foundry customer portfolio following initial challenges. Last June, President Donald Trump announced that Intel would collaborate with Apple on designing and manufacturing semiconductors domestically — a partnership that could substantially strengthen the foundry operation if finalized.
This past April, Intel invested $14.2 billion to reacquire half ownership of the Leixlip complex it had previously divested to Apollo Global Management, demonstrating renewed conviction in its manufacturing trajectory.
Economic Implications for Ireland
For Ireland’s economy, this investment represents substantial significance. International corporations currently comprise 11% of Ireland’s total employment market, having roughly doubled their local workforce throughout the past ten years.
Merely three corporations contribute nearly half of Ireland’s entire corporate tax revenue, creating vulnerability to multinational strategic shifts. Intel’s substantial new investment provides some relief from this exposure.
Irish Prime Minister Micheal Martin described the announcement as “a powerful vote of confidence in Ireland.” The expansion will generate several hundred additional positions beyond Intel’s current 4,900-member Irish team.
Beyond the United States, Intel maintains only one other significant manufacturing operation, located in Israel. The Leixlip campus, with its interconnected facilities across the site, assumes heightened strategic value as Intel competes to maintain position in the worldwide AI semiconductor market.
The post Intel (INTC) Stock Dips as Company Commits €5B to Irish AI Chip Production Hub appeared first on Blockonomi.

Key Points
A coalition of 12 states, led by California, has launched legal action to stop Paramount’s $110 billion merger with Warner Bros. Discovery (WBD)
State officials claim the transaction would eliminate competition in film distribution and cable television markets, potentially raising consumer costs
The merged entity would command 27% of U.S. film distribution and 30% of major blockbuster releases
Federal regulators already approved the transaction last month, citing consumer and worker benefits
Paramount could owe WBD approximately $650 million quarterly if the merger fails to complete by October
California’s top law enforcement official, Attorney General Rob Bonta, initiated legal proceedings on Monday with support from 11 additional states to halt Paramount’s proposed $110 billion acquisition of Warner Bros. Discovery, warning of significant market concentration concerns.
The legal challenge represents a major obstacle to one of the entertainment industry’s largest proposed consolidations and could derail Paramount CEO David Ellison’s strategy to create a streaming powerhouse capable of competing with Netflix and Disney.
WBD shares climbed 2.37% to $27.22 during trading hours when this report was filed.
According to the complaint, the merged company would dominate 27% of nationwide film distribution, capture 30% of the blockbuster film distribution market, and control 27% of basic cable programming — encompassing major networks like CNN, MTV, HGTV, Cartoon Network, and Nickelodeon.
Bonta warned that the consolidation “would lead to higher prices, lower quality, and less content for film and television, harming movie theaters, basic cable distributors, and ultimately, audiences.”
Federal Regulators Already Approved the Transaction
The Justice Department authorized the deal in the previous month, going beyond simple approval to characterize it as advantageous for both consumers and industry employees. This state-level opposition represents an uncommon scenario — directly contradicting federal regulatory approval.
The transaction has attracted scrutiny from Democratic state attorneys general, with several suggesting the Trump administration provided regulatory favoritism to politically connected corporations. Paramount CEO David Ellison’s father, Oracle founder Larry Ellison, has cultivated strong relationships with President Trump. The media company has also brought on board former Trump administration officials.
Paramount has characterized any legal opposition as driven by political motivations.
Financial Implications of the Legal Challenge
Timing is critical in this situation. A judicial decision on the states’ antitrust claims could require several months, and such postponement carries significant financial consequences — potentially reaching hundreds of millions of dollars for Paramount.
According to merger agreement provisions, Paramount faces approximately $650 million in quarterly payments to WBD shareholders should the transaction fail to conclude prior to October.
Company executives have cautioned that extended delays might necessitate renegotiating financing arrangements, create volatility for shareholders, or completely terminate the agreement.
The state coalition has requested that Paramount voluntarily postpone the closing date until litigation concludes. Should Paramount decline, the states indicated they will pursue a judicial injunction to prevent consummation.
Cinema operators have expressed opposition to the consolidation, concerned that merging Warner Bros. and Paramount Pictures would result in reduced theatrical film production. Paramount has countered these concerns, noting plans to eliminate $6 billion in expenses — primarily through infrastructure consolidation, marketing efficiencies, and corporate restructuring — while boosting content production. Ellison has committed that the combined studios would distribute 30 theatrical releases annually.
Industry sources informed CNBC’s David Faber on Sunday that the state-level challenge was anticipated, with California spearheading the multistate effort.
The post Paramount (PSKY) Stock Under Pressure as 12-State Coalition Challenges $110B Warner Merger appeared first on Blockonomi.

Key Takeaways
Bernstein maintains Outperform rating with $239 price target on SpaceX (SPCX) following China’s Long March 10B booster recovery
Shares declined approximately 4% Monday, hovering around $145.30, approaching its 52-week low point
China’s rocket landing occurred half a year sooner than Bernstein’s forecast, though booster reuse hasn’t been proven yet
SpaceX has maintained a Falcon 9 booster reuse program for almost ten years and executed 165 launches in the previous year
Wall Street’s consensus price target on SPCX stands at $246.43, representing potential 76% gains from present valuation
Shares of SpaceX (SPCX) tumbled approximately 4% during Monday’s opening session, settling near $145.30, dangerously close to its yearly low. The decline followed China’s weekend announcement of a successful Long March 10B rocket booster recovery operation.
Bernstein analyst Douglas Harned remained unfazed by the development. He maintained his Outperform stance with a $239 price objective on SPCX, indicating potential gains exceeding 70% from current trading levels.
Harned had just launched his Buy recommendation on SPCX the previous week. His Monday commentary reinforces that bullish position.
On July 10, China successfully recovered the Long March 10B first-stage booster using an offshore recovery platform, a test flight that invited inevitable comparisons to SpaceX’s proven Falcon 9 booster recovery operations. The achievement represents meaningful progress in China’s reusable rocket development efforts.
While Harned recognized the accomplishment, he provided important perspective. The landing occurred approximately six months earlier than his projections suggested, yet he believes the technological divide between China and SpaceX remains substantial.
How China’s Achievement Compares to SpaceX’s Capabilities
The critical difference Harned emphasizes: China has successfully landed a booster, but hasn’t yet relaunched a recovered unit. These represent fundamentally different technical challenges.
SpaceX has been recovering and relaunching Falcon 9 boosters for nearly a decade. Throughout 2025, the company executed 165 launches. This operational cadence stems from years of validated reuse technology, not merely a single successful landing.
China would need to prove consistent relaunch operations and increase production capacity before matching that launch frequency. Harned views this as requiring several years at a minimum.
A hardware distinction deserves attention as well. Long March 10 enables only first-stage reuse. SpaceX’s Starship architecture targets complete reusability — both stages — although that full capability remains unproven in operational service.
Analyst Community Maintains Strong Confidence in SPCX
Beyond Bernstein, numerous analysts have issued favorable ratings since SpaceX’s public offering.
Raymond James established a Wall Street-leading $800 target, suggesting approximately 440% upside potential. Deutsche Bank launched coverage with a Buy recommendation and $255 objective. Macquarie and Clear Street both assigned Outperform and Buy ratings respectively, with price targets of $250 and $217.
According to TipRanks, the consensus rating stands at Strong Buy, derived from 22 Buy recommendations, four Hold ratings, and one Sell. The Street’s average price objective reaches $246.43, implying a 76% appreciation from Monday’s share price.
China continues advancing its broader space program aggressively. The nation has submitted applications to the ITU for deploying over 200,000 satellites in low Earth orbit and is constructing a lunar research facility.
Regardless of these competitive developments, SPCX stock’s consensus analyst target continues trading more than $100 above current market levels.
The post SpaceX (SPCX) Stock Slides 4% Despite Bernstein’s Bullish $239 Price Target appeared first on Blockonomi.

Key Takeaways
RBC Capital’s Steven Shemesh launched coverage on COST with a Hold rating and $1,000 target, suggesting roughly 9% potential upside
The analyst highlighted Costco’s wholesale model, merchandising strength, and expanding online operations as positives
Shemesh cautioned that the stock’s premium valuation already reflects most competitive advantages, with membership expansion expected to decelerate
Ghe LLC boosted its COST position by 121.8% during Q1, expanding its holdings to 13,601 shares valued at approximately $13.55 million
Analyst consensus points to “Moderate Buy” with average targets ranging from $1,061 to $1,095, suggesting potential gains up to 19%
Shares of Costco (COST) climbed 0.84% during Monday’s trading session following RBC Capital’s designation of the warehouse retailer as “one of the best stories in retail” — though the firm simultaneously assigned a Hold rating. The stock began trading at $916.25, notably beneath its 52-week peak of $1,096.50.
Steven Shemesh, an analyst at RBC, launched his firm’s coverage with a $1,000 price objective. This target represents approximately 9% appreciation potential from present trading levels — a reasonable forecast, though hardly an aggressive bullish call.
Shemesh applauded Costco’s warehouse bulk-pricing strategy and highlighted what he described as “strong merchandising” capabilities. He also noted the retailer’s expanding online sales channel as an avenue for incremental margin improvement. Essentially: the business fundamentals are solid, but the market has already recognized this quality.
The analyst’s primary reservation centers on valuation metrics. Nearly all of Costco’s competitive advantages — including its devoted member base, advantageous pricing dynamics, and e-commerce growth potential — are already reflected in the current stock price, according to his assessment. Trading at a PE multiple of 46.09, investors are paying a substantial premium. While Shemesh views this as justified, he questions how much higher it can reasonably go.
He additionally highlighted an anticipated deceleration in paid membership additions and renewal rate trends. Since these metrics are fundamental to Costco’s operating model, any weakness in these areas carries meaningful implications.
Movement Among Institutional Holders
Ghe LLC expanded its COST holdings by 121.8% during the first quarter, acquiring an additional 7,468 shares to bring its total position to 13,601 shares — representing approximately $13.55 million in value. This positions COST as the firm’s fourth-largest investment, accounting for 2.9% of its overall portfolio.
Other institutional players have made smaller adjustments. Manning & Napier Advisors increased its position by 750%, although it maintains just 34 shares. Several firms established new positions in Q4, including Gunpowder Capital Management and Mcguire Capital Advisors. Institutional ownership currently stands at 68.48% of outstanding shares.
Regarding insider transactions, Director Kenneth D. Denman divested 885 shares on June 23rd at an average sale price of $957.45, generating proceeds of $847,343. This transaction reduced his ownership position by 15.62%.
Broader Wall Street Perspective
The overall analyst community maintains a more optimistic stance than RBC. Among analysts who have issued ratings within the past three months, 14 recommend Buy, eight suggest Hold, and one advises Sell — establishing a “Moderate Buy” consensus.
Target prices show considerable variation. JPMorgan made a minor adjustment, reducing its target from $1,110 to $1,100 while maintaining an Overweight rating. Bank of America elevated its target to $1,200 with a Buy recommendation. Goldman Sachs increased its objective to $1,159. BTIG established a $1,125 target. TD Cowen positioned its target at $1,175.
The consensus target across the analyst community falls between $1,061 and $1,095, depending on the compilation source — indicating potential upside of up to 19% from current price levels.
Costco’s latest quarterly results delivered EPS of $4.93, falling just one cent short of the $4.94 consensus estimate. Revenue reached $70.53 billion, surpassing expectations of $70.12 billion.
The company announced a quarterly dividend distribution of $1.47 per share, scheduled for payment on August 7 to shareholders registered as of July 24. On an annualized basis, this equals $5.88 per share, producing a yield of approximately 0.6%.
Costco has also recently enhanced its digital wallet functionality, a move designed to accelerate the checkout process for members.
The post Costco (COST) Stock Climbs as RBC Names Retailer a Top Industry Player Despite Hold Rating appeared first on Blockonomi.

Key Takeaways
Uber is actively opposing Washington D.C. legislation that would permit fully autonomous robotaxi services, claiming it could create a Waymo monopoly.
The rideshare giant advocates for a combined platform where autonomous vehicles and traditional drivers operate together.
D.C.’s proposed legislation includes a $0.15-per-mile fee on robotaxi rides, funding transit infrastructure and driver transition programs.
Waymo supports the legislation, asserting it promotes safety without limiting competitive operations or mandating specific business structures.
Financial analysts maintain a Strong Buy rating on UBER stock, with a mean price target of $108.04 — suggesting 44% potential gains.
A brewing confrontation between Uber and Waymo over Washington D.C.’s autonomous vehicle legislation threatens to redefine the robotaxi landscape — and the stakes couldn’t be higher for both technology giants.
The legislation, presented by D.C. Councilmember Charles Allen in May, aims to modernize the district’s 2012 Autonomous Vehicle Act. If passed, it would permit companies to deploy and operate fully autonomous vehicles for commercial purposes, removing the current requirement for human safety operators.
Uber stands in firm opposition. The company contends that the proposed rules would essentially grant Waymo — simultaneously its business collaborator and emerging competitor — exclusive control over the district’s autonomous taxi sector.
Uber stock (UBER) climbed approximately 0.86% amid heightened focus on the company’s comprehensive autonomous vehicle strategy stemming from the lobbying dispute.
Key Provisions of the Proposed Legislation
Under the proposed framework, companies seeking operational permits would need to maintain liability coverage of at least $5 million and submit accident reports within 8 to 72 hours based on fleet classification. The legislation also establishes a $1 million application charge plus a non-refundable $5 million licensing fee — expenses that opponents argue would restrict market participation to well-capitalized corporations.
Additionally, the bill establishes a $0.15-per-mile levy on robotaxi journeys. Revenue from this tax would be divided equally between public transportation enhancement and workforce development initiatives for drivers facing job displacement from autonomous technology.
Uber’s Alternative Vision
Uber is championing a different approach. The company envisions a unified platform that dynamically connects passengers with either human drivers or autonomous vehicles based on real-time availability and rider requirements. Uber released a detailed white paper outlining this integrated model in May and has launched intensive advocacy efforts in Washington D.C. and other jurisdictions.
Uber’s policy director Javi Correoso contends that autonomous-only services contribute to traffic congestion, lack the capability to properly serve elderly or mobility-impaired passengers, and that each autonomous vehicle effectively eliminates employment opportunities for approximately four human drivers.
Waymo rejects this characterization completely. The Alphabet-backed company maintains that the legislation focuses exclusively on safe deployment standards and doesn’t exclude competitors. Waymo has indicated openness to incorporating language that explicitly permits various operating models within the district.
Both organizations are set to present their positions during an extensive D.C. Council hearing scheduled for Monday.
The friction between these companies has historical roots. Waymo initiated legal action against Uber in 2017 alleging intellectual property theft before reaching a settlement. Subsequently, the companies formed a partnership to integrate Waymo vehicles into the Uber platform across Phoenix, Austin, and Atlanta. That alliance has noticeably deteriorated in recent months, with Uber’s Chief Technology Officer publicly questioning Waymo’s vehicle performance on X, and CEO Dara Khosrowshahi making critical comments regarding AV safety during a May earnings discussion.
Meanwhile, Uber is cultivating partnerships with over 30 autonomous vehicle developers worldwide and establishing an in-house unit called AV Labs dedicated to gathering and distributing real-world driving intelligence.
Financial analysts remain optimistic about Uber’s prospects. The consensus rating for UBER stock stands at Strong Buy, supported by 28 Buy recommendations, two Hold ratings, and zero Sell ratings recorded over the past three months. The consensus price target is set at $108.04.
The post Uber (UBER) Stock Rallies as Company Challenges D.C. Robotaxi Legislation Favoring Waymo appeared first on Blockonomi.

TLDR
Bolivia is reviewing whether USDT can join its national payments system.
USDT could circulate alongside the boliviano and the U.S. dollar.
The government has not granted USDT legal-tender status or issued rollout rules.
Banks, wallets, and payment providers may operate under a regulated framework.
Crypto transaction volume rose sharply after restrictions ended in June 2024.
Bolivia is weighing whether to add Tether’s USDT stablecoin to its national payments system. The proposal could allow USDT to circulate alongside the boliviano and the United States dollar. However, Bolivia has not approved implementation rules or granted the token legal-tender status.
Government Reviews USDT Payment Framework
Economy Minister José Gabriel Espinoza confirmed that officials are conducting a technical assessment of the proposal. Bolivia is also preparing rules for banks, digital wallets, and payment service providers. The framework would define how regulated institutions could support stablecoin payments.
Bolivia has not announced a launch date or detailed operating requirements. Officials must also determine how USDT transactions would interact with existing currency and banking regulations. These reviews will shape whether the stablecoin enters the formal payments network.
Any approval would require stronger financial crime controls across participating institutions. Bolivia remains on the Financial Action Task Force’s grey list because of weaknesses in its financial safeguards. Banks and payment companies would therefore need tighter monitoring and reporting systems.
Crypto Use Expands After Restrictions End
The central bank removed restrictions on cryptocurrency transactions in June 2024. Since then, Bolivia has recorded a sharp increase in digital asset activity. Transaction volume reached $294 million during the first half of last year.
The comparable figure stood at $46.5 million during the first half of 2024. The central bank said total transaction volume increased 630% after authorities removed the restrictions. This growth shows rising use of digital assets within the country’s financial system.
Demand has grown as companies and consumers seek alternatives to limited dollar supplies. Bolivia also ended its fixed dollar peg and adopted a floating exchange rate earlier this year. Those changes have increased interest in dollar-linked payment options.
Banks and State Companies Test Crypto Services
State-controlled Banco Unión expanded access to USDT through its Yasta digital wallet in April. Customers can buy the stablecoin through EFY Finance for remittances and international payments. The service gave Bolivia an early regulated channel for stablecoin purchases.
State energy company YPFB also announced plans to use cryptocurrency for energy imports last year. The central bank has sought guidance from El Salvador while developing its digital asset framework. These steps show broader government interest in controlled cryptocurrency use. The latest proposal would place USDT within a wider national payment structure. Bolivia must still complete technical reviews and publish formal rules before any rollout begins.
The post Bolivia Reviews USDT Role Alongside Boliviano and Dollar appeared first on Blockonomi.

TLDR
Apple shares climbed 15% and added nearly $600 billion since June 25.
Lower AI infrastructure spending has reduced financial pressure compared with major technology rivals.
The company became the best-performing Magnificent Seven stock in 2026.
Citi raised its price target to $365 and maintained a Buy rating.
Analysts view the foldable iPhone as the next major growth catalyst.
Apple shares have surged as Wall Street questions the returns from heavy artificial intelligence spending. The stock has gained 15% since June 25 and added nearly $600 billion in market value. Analysts now see the foldable iPhone as the next major catalyst for further growth.
AI Restraint Strengthens Market Position
Apple has benefited as investors reduce exposure to chipmakers and cloud companies carrying large AI costs. The Philadelphia Semiconductor Index fell 7% during the same period, despite strong annual gains. Meanwhile, the S&P 500 rose 3%, and the Nasdaq 100 advanced only 1.3%.
Apple has avoided the expensive race to build large artificial intelligence data centers. That strategy once raised concerns that the business could fall behind major technology rivals. However, market sentiment shifted as questions grew over returns from hyperscaler spending and expanding infrastructure budgets.
Mark Bronzo said the company was benefiting because it remained outside the wider AI spending storm. He said investors questioned hyperscaler returns and believed semiconductor valuations had moved too far. As a result, investors returned to Apple as a stable company with fewer spending risks.
Pricing Power Supports Earnings Outlook
Rising memory chip prices have increased cost pressure across the consumer electronics industry. Apple raised prices for Macs, iPads, and home devices on June 25. The move initially triggered the stock’s steepest daily decline since April 2025.
The company has kept iPhone prices unchanged, although further increases remain possible. Apple is also negotiating with Chinese chipmakers to diversify memory supplies and reduce procurement costs. Analysts believe its premium customer base provides greater room to pass on higher component expenses.
JPMorgan analyst Samik Chatterjee raised his price target to $345 after reviewing historic pricing trends. He said price increases had shown limited effects on long-term sales volumes across several product cycles. Citi also lifted its target to $365 and maintained a Buy rating on Apple.
Foldable iPhone Becomes Next Catalyst
Citi expects Apple to keep gaining smartphone market share despite weaker global industry demand. The bank cited product design, promotions, subsidies, and strength in mid-range price segments. It also expects higher iPhone prices during the September product launch cycle.
Nikkei reported that suppliers were preparing to produce about 10 million foldable iPhones this year. That figure exceeded an earlier estimate of seven million to eight million units. Analysts expect premium pricing to help Apple offset higher component costs and support revenue growth.
Apple could generate nearly $140 billion in free cash flow during 2026, according to current analyst forecasts. Analysts also forecast almost 15% revenue growth and a 17% increase in net income. The stock’s recovery now reflects restrained AI spending, pricing power, and expectations for a foldable iPhone.
The post Apple Stock Rallies as AI Restraint Wins Investor Support appeared first on Blockonomi.

Key Highlights
BAC shares declined 0.80% amid announcement of nationwide banking team expansion.
Financial institution recruits experienced bankers for enhanced middle market services.
BAC stock retreats as Bank of America reinforces investment banking division.
Strategic regional banking expansion includes seasoned executive appointments.
Senior leadership additions align with Bank of America’s expansion objectives.
Shares of Bank of America (BAC) experienced a 0.80% decline, settling at $59.19 following initial downward pressure during trading hours. The stock managed to reclaim some ground throughout the session yet failed to reach the prior day’s closing price. The financial institution revealed significant expansion plans for its Regional Investment Banking division spanning critical markets throughout the nation.
Bank of America Corporation, BAC
Financial Giant Enhances Middle Market Banking Capabilities
Bank of America recruited multiple veteran investment banking professionals to broaden its Regional Investment Banking operations throughout the country. These strategic appointments enhance senior-level representation in major cities including Austin, Boston, Charlotte, Chicago, Detroit, Minneapolis, New York, San Francisco, and West Palm Beach. The newly appointed executives will operate under the direction of Regional Investment Banking co-leaders Neil Kell and Samardh Kumar.
This expansion initiative aligns with Bank of America’s comprehensive approach to enhancing service offerings for middle market enterprises. The institution aims to bolster advisory services, capital markets assistance, and transaction expertise. This strategic move simultaneously expands client engagement throughout Global Commercial Banking divisions.
Regional Investment Banking integrates resources from Global Commercial Banking, Merrill, Private Bank, and Local Market Organization. This organizational framework provides comprehensive financial solutions through localized partnerships supported by worldwide resources. The approach enhances collaboration throughout Bank of America’s 97 local markets while driving organizational advancement.
Seasoned Banking Professionals Join Regional Operations
The recent appointments introduce accomplished professionals spanning diverse industries and territories. Bob Berry will arrive at the Boston location in late July following distinguished advisory tenures at Rothschild, Truist, Raymond James, and Credit Suisse. Similarly, Matt Dalton will commence work in Minneapolis during early August after accumulating over 17 years guiding industrial sector clients at Lazard.
Rick Florjancic will assume leadership of the Chicago operation starting in September following service at BMO Capital Markets, Wells Fargo, and J.P. Morgan. Ian Mackay will enhance financial sponsor services from Charlotte after holding key positions at BlackArch Partners, Raymond James, and SunTrust. Joe Winters will similarly broaden Bank of America’s Northern California footprint after departing from J.P. Morgan.
The institution also secured Joe Park for Detroit, Daniel Webb for Austin, Bo Brown for New York, and Mitch Theiss for West Palm Beach. Each professional contributes substantial expertise spanning investment banking, corporate transactions, technology sectors, industrial operations, or executive management. Collectively, these appointments fortify regional advisory strength while broadening client networks across vital American markets.
Growth Initiative Advances Ongoing Middle Market Focus
Bank of America has persistently expanded its Regional Investment Banking infrastructure since establishing the division in 2016. The network currently encompasses 26 American cities and employs over 200 investment banking specialists. The platform has incorporated operations in 20 additional cities throughout this timeframe.
The financial institution views middle market enterprises as a vital driver of organizational growth, job creation, and economic investment nationwide. Leadership continues allocating resources toward relationship-focused banking and tactical financial guidance. The broadened coverage additionally assists companies pursuing capital access, strategic acquisitions, and sustained expansion prospects.
This hiring initiative underscores Bank of America’s dedication to capturing greater market position within its middle market segment. Furthermore, the supplementary talent strengthens sector expertise across numerous critical industries and territories. Although shares concluded trading in negative territory, the expansion demonstrates ongoing commitment to the institution’s extended commercial and investment banking vision.

The post Bank of America (BAC) Stock Dips Amid Strategic Investment Banking Expansion appeared first on Blockonomi.

TLDR
Intel shares fell 4.6% to $104.81 during morning trading.
SK Hynix’s record 15% decline triggered a global semiconductor selloff.
JPMorgan named Intel a top short idea after its strong 2026 rally.
Intel announced a €5 billion expansion of its manufacturing campus in Ireland.
Concerns over 18A yields and AMD’s data-center gains pressured sentiment.
Intel will report its second-quarter financial results on July 23.
Intel stock (NASDAQ: INTC) fell 4.6% to $104.81 during Monday morning trading as semiconductor shares weakened worldwide. The decline followed SK Hynix’s record plunge and spread across Asian, European, and United States chip markets. Intel stock also faced pressure from a bearish JPMorgan call and unresolved manufacturing concerns.
SK Hynix Collapse Triggers Global Chip Selloff
SK Hynix shares dropped more than 15% in Seoul, marking their steepest single-session decline on record. A domestic brokerage projected second-quarter operating profit would miss market expectations by about 8%. The report cited weaker average selling price growth for high-bandwidth memory products.
That forecast quickly affected semiconductor trading beyond South Korea and weighed on major chip companies. Intel stock moved lower during premarket trading and extended those losses after United States markets opened. The broader decline reflected renewed concerns about pricing strength across the memory and data-center chip industries.
South Korea’s Kospi index fell about 9% and triggered a temporary circuit-breaker trading halt. European chipmakers ASML, ASMI, and Infineon declined between 1% and 2% during regional trading. Intel stock weakened alongside those losses as global markets reduced exposure to semiconductor companies.
JPMorgan Short Call Adds Company Pressure
JPMorgan named Intel a top short idea after the shares more than doubled during 2026. The bank argued that expectations already reflected a foundry and artificial intelligence recovery. However, Intel has not yet shown that recovery through reported financial results.
Intel stock also remains affected by questions surrounding the company’s advanced 18A manufacturing process. Profitable production yields may not arrive until late 2026 or sometime during 2027. Those timelines raise execution risks as Intel expands its contract manufacturing operations.
AMD recently reported its first quarterly lead over Intel in data-center revenue, increasing competitive pressure. That shift highlighted Intel’s need to improve product performance and secure stronger customer demand. Intel stock now trades below its 52-week high of $142.35 after its earlier rally.
Ireland Investment Fails to Offset Market Weakness
Intel announced a €5 billion investment to expand its manufacturing campus in Leixlip, Ireland. The project will support data-center processor production and provide additional foundry manufacturing capacity. However, the announcement did not reverse the decline in Intel stock during morning trading.
Broader market weakness added pressure as the Nasdaq Composite dropped 1.2% during the session. The S&P 500 fell 0.5%, while the Dow Jones posted a smaller decline. Intel stock remained among the semiconductor names affected by the market’s risk-off positioning.
Intel stock faces its next major test when the company reports second-quarter results on July 23. The report will provide updated figures on revenue, margins, foundry spending, and data-center demand. Intel stock ended the morning lower as sector selling, analyst pressure, and execution concerns converged.
The post Intel Stock Retreats as Foundry and AMD Concerns Deepen appeared first on Blockonomi.

TLDR
Tesla delivered 480,126 vehicles, beating the second-quarter consensus by about 18%.
Vehicle deliveries exceeded production, indicating Tesla reduced finished vehicle inventories during the quarter.
Analysts raised second-quarter earnings and revenue estimates before the July 22 results.
Tesla reported two consecutive normalized earnings beats before the latest delivery update.
Energy storage deployments reached 13.5 GWh, marking 53% quarterly growth.
Tesla stock enters its July 22 earnings report after quarterly deliveries exceeded market forecasts by a wide margin. The company also posted recent profit and revenue beats, while analysts raised estimates before the scheduled second-quarter financial results. However, wide forecast ranges and robotaxi execution risks still complicate Tesla stock and its longer-term valuation assumptions before the upcoming report.
Delivery Beat Reshapes Near-Term Earnings Expectations
Tesla delivered 480,126 vehicles during the second quarter, compared with a sell-side consensus estimate of 406,024 total units. The result exceeded consensus by about 74,000 vehicles, representing an approximate 18% beat against prevailing market delivery expectations. Tesla stock gained support from the report, which also surpassed higher delivery forecasts published by Barclays and Morgan Stanley.
The company produced 451,758 vehicles, while deliveries exceeded production and indicated a meaningful reduction in finished vehicle inventories. Model 3 and Model Y deliveries reached 467,762 units, compared with combined quarterly production of 442,936 total vehicles. That difference shows Tesla cleared existing inventory during the quarter rather than adding more unsold vehicles to company storage.
The delivery performance followed a first-quarter earnings beat and stronger-than-expected revenue, extending the company’s improving operational performance sequence. Normalized earnings reached $0.41 per share, above the $0.35 estimate, while quarterly revenue reached $22.39 billion overall. Tesla stock now approaches earnings after two consecutive positive profit surprises and a quarterly delivery result well above consensus.
Analysts Raise Forecasts Before July Results
The second-quarter normalized earnings consensus stands at $0.50 per share, representing expected annual growth of 24.41% for Tesla. Analysts raised that estimate by 8.89% during one month and 10.04% across the previous three reporting months. Those revisions changed the setup for Tesla stock because estimates increased after the company reported stronger quarterly vehicle deliveries.
Revenue estimates also moved higher, with consensus now forecasting $25.83 billion for Tesla during the upcoming second quarter. That figure represents 14.82% annual growth and reflects a 4.8% increase from the estimate one month earlier. The revenue revision gives Tesla stock a higher earnings hurdle, although deliveries already exceeded the market’s earlier baseline.
Longer-term forecasts also show Tesla expanding beyond its established Model 3 and Model Y vehicle product mix. Analysts expect deliveries from those established vehicle models to rise 39% from fiscal 2026 through fiscal 2030. Meanwhile, forecasts project new-vehicle deliveries rising 546%, increasing their contribution to Tesla’s total future sales and revenue mix.
Energy Growth Meets Autonomy and Regulatory Risks
Tesla deployed 13.5 gigawatt-hours of energy storage during the quarter, representing 53% sequential growth from the first-quarter base. The result came slightly below the 13.8 gigawatt-hour consensus, but it showed continued expansion outside Tesla’s core automotive operations. Tesla stock therefore carries growing exposure to an energy business expected to reach 150.1 gigawatt-hours by fiscal 2030.
However, short-term earnings estimates remain widely dispersed, showing limited agreement among analysts currently covering the global electric-vehicle company. The second-quarter earnings range spans $0.26 to $0.74 per share, based on forecasts submitted by 27 analysts. That spread creates uncertainty around Tesla stock even as the central estimate has moved higher before the earnings release.
Longer-term forecasts depend partly on autonomy, robotaxi services, and Optimus, while those businesses face operational and regulatory constraints. Bloomberg reported booking delays and service failures during testing of Tesla’s Austin robotaxi operation, which included only 59 vehicles. Tesla stock also reflects legal exposure from driver-assistance investigations, crash cases, settlements, and a previous $243 million civil jury verdict.
Tesla’s earnings setup now combines stronger deliveries, rising estimates, expanding energy deployments, and two recent consecutive quarterly earnings beats. Yet forecast dispersion, robotaxi limitations, and regulatory cases continue to affect the reliability of longer-term company financial projections. Tesla stock will enter the July 22 report with improved operating data, but several material execution risks remain unresolved.
The post Tesla Stock Earnings Setup Shifts After Major Delivery Beat appeared first on Blockonomi.

TLDR
L’action Nvidia a chuté de 1,8 % à 207,11 $ lors des premiers échanges lundi.
Les actions ont reculé malgré le fait que Meta a élargi ses dépenses pour son centre de données en Louisiane, au-delà de 50 milliards de dollars.
Nvidia a gagné 12 % cette année, tandis que l’indice PHLX Semiconductor a progressé de 75 %.
Les analystes de Wall Street maintiennent un objectif de cours moyen pour Nvidia à 313,39 $.
Mizuho s’attend à ce que Nvidia profite de 1 200 milliards de dollars de dépenses dans les centres de données l’an prochain.
L’action Nvidia a baissé lors des premiers échanges lundi malgré une nouvelle annonce importante de dépenses dans l’intelligence artificielle de la part de Meta Platforms. Les actions ont reculé de 1,8 % à 207,11 $ tandis que les valeurs technologiques et des semi-conducteurs s’affaiblissaient sur l’ensemble du marché. Toutefois, l’action Nvidia continue de prendre du retard sur le secteur plus large des puces malgré une forte demande pour des infrastructures de calcul avancées.

Points clés
Les actions de BURU chutent de 11,95 % après l’annonce d’une offre publique de titres de 38 M$.
Levée de fonds destinée à rembourser les obligations de dette et à financer l’acquisition de Tekne S.p.A..
Offre structurée pour renforcer les capitaux propres des actionnaires et satisfaire aux exigences d’inscription à la cote du NYSE.
Titres valorisés à 5 % au-dessus du cours de clôture du 10 juillet dans l’opération proposée.
Produit destiné à mettre fin aux tirages sur la ligne de capitaux propres et à alimenter des initiatives de croissance stratégique.
Les actions de Nuburu, Inc. (BURU) ont subi une pression baissière significative après la divulgation par la société d’un projet d’offre publique de titres. Le titre a reculé de 11,95 % pour clôturer à 0,1304 $ dans un contexte de ventes soutenues. Cette levée de fonds est structurée pour rembourser les obligations en cours, renforcer les ressources financières et faire progresser les stratégies d’acquisition.

TLDR
Les actions de MSTR ont reculé de 4,5 %, à 90,54 $ US, dans un contexte de baisse d’environ 3 % du Bitcoin, qui évoluait dans une fourchette de 62 260 à 62 800 $ US.
La société a généré 466,7 millions de dollars via des émissions d’actions ordinaires, portant sa réserve de trésorerie à 3 milliards de dollars.
La position de Strategy en Bitcoin reste inchangée, à 843 775 BTC, avec un coût d’acquisition moyen de 75 476 $ par pièce.
La réserve de trésorerie accumulée sert exclusivement à financer les obligations de dividendes privilégiés et les intérêts sur la dette en circulation.
La direction de l’entreprise a autorisé des ventes potentielles de Bitcoin pouvant atteindre 1,25 milliard de dollars afin de renforcer le fonds de réserve désigné.

Key Highlights
RY shares peaked at $211.39 on Monday, closing at $211.73
Q2 earnings per share of $2.84 surpassed the Street estimate of $2.81
Dividend increased to $1.76 per share from $1.64, delivering approximately 3.3% annual yield
The bank completed a $2.3 billion debt offering via Senior Global Medium-Term Notes on July 10
Wall Street consensus leans “Moderate Buy” with $225 average target price
Royal Bank of Canada (RY) registered a fresh 52-week peak on Monday, climbing to $211.39 intraday before closing at $211.73, marking approximately 0.4% gains for the session. The stock finished the prior trading day at $211.09.
The upward momentum has been sustained. The 50-day moving average currently rests at $194.71, while the 200-day moving average stands at $177.97—both considerably beneath today’s trading level.
RBC’s valuation sits at roughly $294.62 billion in market capitalization, accompanied by a price-to-earnings multiple of 19.07 and a beta coefficient of 0.80.
During its latest quarterly report released May 28, RBC delivered earnings per share of $2.84, narrowly topping analyst expectations of $2.81. Top-line figures reached $12.84 billion, surpassing the projected $12.74 billion and representing an 11.4% year-over-year increase.
The bank achieved a return on equity of 17.68% alongside a net profit margin of 15.92%. The Street’s full-year EPS projection currently stands at $11.45.
Quarterly Dividend Increase
RBC announced an elevation of its quarterly dividend from $1.64 to $1.76 per share. Shareholders of record as of July 27 will receive the distribution on August 24. This translates to an annualized yield near 3.3%, supported by a payout ratio of 44.47%.
The dividend enhancement reflects management’s optimism regarding the institution’s earnings outlook going forward.
Fresh Capital Raise Through Debt Markets
On July 10, RBC secured $2.3 billion in fresh capital through issuing Senior Global Medium-Term Notes under its existing U.S. shelf registration framework. The transaction comprised $1.0 billion in 4.652% fixed/floating notes maturing in 2029, $300 million in floating rate notes also due 2029, and $1.0 billion in 4.950% fixed/floating notes with a 2032 maturity.
This debt issuance operates within RBC’s established $75 billion borrowing program and received legal validation from Sullivan & Cromwell LLP alongside Norton Rose Fulbright Canada LLP.
Institutional money managers have expanded their positions recently. AQR Capital Management boosted its holdings by 60.9% during Q1, while Baird Financial Group expanded its stake by 39.1% in Q2. Sivia Capital Partners increased exposure by 57.7% in the second quarter. Collectively, institutional shareholders control 45.31% of outstanding shares.
Among sell-side analysts covering the stock, 10 of 14 maintain Buy ratings on RY, with the remaining 4 at Hold.
The Street’s average target price sits at $225, suggesting potential upside around 6% from current trading levels. Argus established that $225 target in June, whereas Raymond James downgraded to Market Perform in May.
TD Securities confirmed its Buy recommendation on May 29. Weiss Ratings made a minor adjustment lower to its grade in late June while maintaining a Buy-equivalent stance.
The latest price target assigned to the TSX-listed shares is C$305.00, also carrying a Buy rating.
The post Royal Bank of Canada (RY) Stock Reaches Fresh 52-Week Peak: Here’s Why appeared first on Blockonomi.

Faits marquants
La Bolivie envisage de reconnaître l’USDT comme un moyen de paiement officiel aux côtés de sa monnaie nationale.
Les institutions bancaires élargissent les offres de l’USDT en réponse à l’intérêt croissant pour les stablecoins.
La rareté des devises pousse la Bolivie vers des alternatives de paiement numériques réglementées.
Les responsables élaborent des réglementations complètes avant d’autoriser une utilisation étendue de l’USDT.
La Bolivie progresse dans l’adoption de la finance numérique grâce à des mises à jour institutionnelles et du système de paiement.
La Bolivie examine actuellement une proposition visant à intégrer l’USDT à son infrastructure de paiement alors que le pays s’ouvre aux actifs financiers numériques. Cette initiative permettrait au stablecoin de fonctionner aux côtés à la fois du dollar américain et de la monnaie nationale bolivienne. Parallèlement, les institutions financières élargissent leurs capacités en matière de stablecoins tandis que les autorités gouvernementales formulent des lignes directrices réglementaires complètes.

Key Highlights
Agenus shares climbed 13% during premarket hours Monday following the announcement of an $85 million private placement
Commodore Capital spearheaded the investment round, joined by RA Capital Management, TCGX, Invus, and Ligand Pharmaceuticals
The deal structure incorporates an extra $255 million if all purchase warrants get exercised, potentially reaching $340 million total
Funds will support the ROBBIN Phase 3 clinical trial, extending the company’s cash position through the end of 2031
The company announced plans to withdraw financial backing for its BATTMAN Phase 3 study targeting late-stage metastatic MSS colorectal cancer
Shares of Agenus (AGEN) surged 13% in premarket activity Monday morning following the biotech company’s announcement of an $85 million private financing arrangement.
The biotechnology firm executed a securities purchase agreement delivering $85 million in immediate gross proceeds. Beyond this initial capital injection, there’s potential for another $255 million should investors fully exercise their purchase warrants — establishing a maximum aggregate value of $340 million.
Commodore Capital took the lead investor position in this financing round. Additional participants included RA Capital Management, TCGX, Invus, and Ligand Pharmaceuticals.
Agenus intends to direct these funds toward its ROBBIN Phase 3 clinical trial, which evaluates the botensilimab and balstilimab combination treatment for microsatellite-stable colon cancer.
Assuming complete warrant exercise, the company projects sufficient capital reserves extending through December 2031. This represents a substantial runway extension for a business currently valued at approximately $139.5 million in market capitalization.
BATTMAN Study Defunding
Simultaneously, Agenus revealed its intention to cease financial backing for the BATTMAN Phase 3 clinical study. This trial had been investigating treatments for advanced metastatic MSS colorectal cancer.
The strategic choice to withdraw support from BATTMAN while intensifying investment in ROBBIN reflects a deliberate reallocation of corporate resources. Management appears focused on channeling capital toward what it identifies as the highest-potential pipeline asset.
The ROBBIN study addresses the identical MSS colorectal cancer indication, employing the botensilimab and balstilimab combination therapy. This cancer subtype presents significant treatment challenges with few available therapeutic options, making it the centerpiece of Agenus’s near-term strategy.
Company Financials
The financial metrics reveal a complicated situation. Agenus holds a GF Score of 59 out of 100, suggesting moderate prospects for long-term returns. Its financial strength rating stands at merely 3 out of 10, highlighting significant concerns regarding debt levels and operational expenses.
The profitability metric registers similarly weak at 2 out of 10. Growth performance ranks marginally higher at 4 out of 10.
The present P/E ratio of 2.11x falls significantly beneath standard biotech sector benchmarks. This compressed valuation reflects investor risk assessment rather than representing an obvious value opportunity.
Insider transaction activity shows no purchases or sales over the past twelve months.
The premarket price action places the stock firmly on the radar for traders monitoring small-cap biotech movements Monday. For perspective, Agenus commanded a market capitalization near $139.5 million prior to today’s trading.
The $340 million maximum potential funding — contingent on complete warrant exercise — would exceed twice the company’s present market capitalization.
Commodore Capital’s leadership role in the financing, supported by a consortium of seasoned healthcare investment firms, lends some institutional validation to the arrangement despite Agenus’s financial headwinds.
The company’s next critical catalyst will be developmental updates from the ROBBIN Phase 3 trial as it progresses through clinical stages.
The post Agenus (AGEN) Stock Jumps 13% on Major $340M Financing Agreement appeared first on Blockonomi.

Key Takeaways
Q2 fiscal 2026 earnings release scheduled for Thursday, July 16, before market hours
Analyst consensus points to EPS between $4.84 and $4.85, marking an 18.6% year-over-year jump
Revenue projections range from $110.05B to $110.76B, representing approximately 1.4% annual decline
Options market suggests potential 6.27% stock movement following earnings announcement
Shares have climbed approximately 30% so far this year ahead of the quarterly report
UnitedHealth Group is scheduled to unveil its second-quarter fiscal 2026 financial results before trading begins on Thursday, July 16. The healthcare giant has enjoyed impressive momentum throughout 2026, with shares climbing roughly 30% year-to-date.
Financial analysts tracking the company are projecting earnings per share ranging from $4.84 to $4.85 for the period. This estimate would mark an 18.6% improvement versus the corresponding quarter in the prior year, according to Wall Street consensus.
Regarding top-line performance, the analyst community anticipates UnitedHealth will generate between $110.05 billion and $110.76 billion in quarterly revenue. This projection indicates a modest year-over-year decrease of approximately 1.4% compared to the second quarter of 2025.
The options market signals significant volatility expectations surrounding the earnings announcement. Data from TipRanks’ Options Tool indicates traders are positioning for an approximately 6.27% swing in UNH shares following the results disclosure.
A critical performance indicator to monitor will be the Medical Care Ratio. Analyst projections place this metric at 88.6%, showing improvement from the 89.4% recorded during last year’s comparable period. This ratio improvement would indicate enhanced efficiency, with lower medical expense outlays relative to premium income.
Segment Revenue Projections
Analyst forecasts detail expected performance across UnitedHealth’s various business operations. Premium revenue is anticipated to reach $85.93 billion, reflecting a 2.2% year-over-year contraction. Meanwhile, services revenue should climb to $9.55 billion, representing 5.6% annual growth.
Products revenue forecasts stand at $13.68 billion, indicating a modest 0.9% uptick. Investment and miscellaneous income is expected to total $1.03 billion, down 7.3% from the prior year.
Optum’s healthcare services division has emerged as a significant contributor to UNH’s strong market performance throughout the year. This growth, combined with higher premium pricing and expanding profit margins, has fueled investor enthusiasm.
Membership Metrics Under Scrutiny
Subscriber counts represent another area of intense analyst focus. Projections indicate total domestic commercial membership will reach 29.53 million, declining from 29.97 million in the year-ago period.
Risk-based commercial membership is forecast to drop to 7.26 million from 8.44 million recorded in Q2 2025. Conversely, fee-based commercial members are expected to expand to 22.27 million, up from 21.53 million previously.
Combined Community and Senior membership should total 18.70 million, down from 20.15 million last year. Medicare Advantage enrollment is projected at 7.43 million, compared with 8.35 million in the corresponding quarter last year.
Medicare Part D standalone membership forecasts point to 2.68 million enrollees, representing a decline from 2.80 million a year earlier.
Consensus earnings estimates have remained unchanged throughout the past month, with analysts maintaining their projections without revisions. This consistency might indicate confidence among Wall Street professionals regarding their forecasts—although the substantial 6.27% implied volatility from options pricing suggests market participants are prepared for surprises.
UnitedHealth’s most recent quarterly disclosure occurred in April. With shares already up 30% year-to-date, expectations are elevated heading into Thursday’s announcement, potentially making it more challenging to exceed market anticipations.
The post UnitedHealth (UNH) Q2 Earnings Preview: Wall Street Predictions for July 16 Report appeared first on Blockonomi.